Skip to content
Free shipping over $150 · $50 minimum order · Ships in 1–3 business days · COA for every lot
Log in
Peptides 99.17% purity Research Use Only · Not for Human or Veterinary Consumption

Thymosin Alpha-1

Thymosin Alpha-1 supplied as a lyophilised 10 mg vial. Tested at 99.17% purity by an independent laboratory. Certificate published under lot RP218-16Mar26-14.

Purity
99.17% HPLC
Mol. weight
3108.3 g/mol
Sequence
Ac-SDAAVDTSSEITTKDLKEKKEVVEEAEN
Current lot
RP218-16Mar26-14 COA →
$84.99 $59.99 per vial, 10 mg

Quantity — volume pricing

30 ml +$14.99
In stock Lot RP218-16Mar26-14 View COA → $50 minimum order

At a glance

98+

Third-party purity

Every lot has a certificate from an independent laboratory, typically for HPLC purity and identity.

1–3

Business days to dispatch

Orders are usually prepared for shipment within 1–3 business days, then tracked end to end.

COA

Published before purchase

Read the latest certificate for the compound before you place the order, not after.

Certificate of analysis

The laboratory's report for the current lot

The certificate of analysis an independent laboratory issued for the lot listed here: typically purity by HPLC and identity, and endotoxins where the laboratory tested them.

Lot RP218-16Mar26-14
Purity 99.17% HPLC
Identity Confirmed by HPLC · 14.79 mg per vial
Laboratory Prime Analytical Laboratories
Tested March 17, 2026

Specification

Purity
99.17% by HPLC
Sequence
Ac-SDAAVDTSSEITTKDLKEKKEVVEEAEN
CAS number
62304-98-7
Molecular weight
3108.3 g/mol
Molecular formula
C129H215N33O55
Physical form
Lyophilised white powder
Net quantity
10 mg per vial
Current lot
RP218-16Mar26-14
Tested by
Prime Analytical Laboratories
SKU
PFL-THYMOSIN-ALPHA-1-10-MG

Storage & reconstitution

Before opening

Lyophilised powder is stable at ambient temperature in transit. On arrival, keep sealed vials refrigerated at 2–8 °C, dry and dark. For storage beyond three months, keep at −20 °C.

Reconstitution

Follow your laboratory's own protocol.

After reconstitution

Refrigerate at 2–8 °C and protect from light. Use within 30 days. Discard if the solution becomes cloudy or discoloured.

For laboratory research use only. Not for human or veterinary consumption. Not a drug or dietary supplement.

Research record

Three characterised lines of work

Thymosin Alpha 1 is a synthetic peptide that has been studied for its role in modulating immune pathways and cellular processes. Research has explored its potential applications in areas such as immune response cellular signaling and mechanisms related to homeostasis and tissue dynamics. Its properties have made it a focus of interest in studies involving regulatory functions within biological systems.

01

T-cell compartment and kinetics

A synthetic polypeptide described as modulating the immune system by augmenting T-cell function, with the proposed route being an action on thymocytes that either stimulates their differentiation or converts them to active T cells. The pharmacokinetics reported in the same review are short: rapid absorption with peak serum concentrations within two hours, a serum half-life of roughly two hours, and a return to baseline within 24 hours.

02

Hepatitis B record

This is where the clinical literature is densest. A 2001 review summarised 195 patients across four trials, including one study reporting hepatitis B virus DNA clearance at six months in 9 of 17 patients given the peptide against 10 of 16 given interferon alfa-2b and 4 of 15 historical controls, and an open-label trial reporting clearance in 53 percent at six months. A 2015 review of the subsequent work describes monotherapy as suppressing viral replication relative to untreated controls or conventional interferon, with combination against lamivudine or interferon alfa reported to show better DNA suppression and HBeAg seroconversion.

03

Critical-illness trials

A review of sepsis studies reports reduced mortality, improved HLA-DR expression on monocytes and fewer secondary infections with the peptide alone or in combination, while stating that sepsis is heterogeneous enough that these results cannot be generalised to all patients. An open-label randomised pilot in 49 hospitalised patients with COVID-19 found higher incidence of clinical recovery in the treated group on both low-flow and high-flow oxygen, but neither difference reached significance, with the clearer signal being a 3.84-fold greater rise in CD4+ T cells by day 5 in the low-flow stratum.

Published research areas

Research area Assay
Macrophage polarisation M2 phenotype after oncolytic adenovirus in tumour models
Structural characterisation Circular dichroism, NMR and crystallography of an intrinsically unstructured peptide

The clinical trials behind this compound are in chronic hepatitis B, sepsis and COVID-19, which are not the settings it is generally marketed for. Where the trials are recent they are small and cautious about themselves: the COVID-19 pilot ran to 49 patients and its recovery differences did not reach significance in either oxygen stratum, and the sepsis review states plainly that its results cannot be generalised across so heterogeneous a syndrome. The compound holds no FDA approval.

Regulatory status as of October 2026.

Structure

Thymosin Alpha-1 2D structure

2D structure · PubChem CID 16130571

References

  1. 1 Ancell CD, Phipps J, Young L (2001) Thymosin alpha-1. Am J Health Syst Pharm. 10.1093/ajhp/58.10.886
  2. 2 Wu X, Jia J, You H (2015) Thymosin alpha-1 treatment in chronic hepatitis B. Expert Opin Biol Ther. 10.1517/14712598.2015.1007948
  3. 3 Pei F, Guan X, Wu J (2018) Thymosin alpha 1 treatment for patients with sepsis. Expert Opin Biol Ther. 10.1080/14712598.2018.1484104
  4. 4 Shehadeh F et al. (2023) A pilot trial of thymalfasin in hospitalized patients with COVID-19. J Infect Dis. 10.1093/infdis/jiac362
  5. 5 Hoch K, Volk DE (2016) Structures of thymosin proteins. Vitam Horm. 10.1016/bs.vh.2016.04.009
  6. 6 Liu K et al. (2024) Thymosin alpha 1 reverses oncolytic adenovirus-induced M2 polarization of macrophages. Cell Rep Med. 10.1016/j.xcrm.2024.101751
  7. 7 Simonova MA et al. (2025) Aging and thymosin alpha-1. Int J Mol Sci. 10.3390/ijms262311470

Common questions

Ordering, handling and compliance. Anything not covered here, write to support@pureforgelabs.com.

What does research use only actually mean?

Every compound we sell is supplied for laboratory research and development only. It is not a drug, not a supplement, and not intended to diagnose, treat, cure or prevent any condition in humans or animals. Buying from this site means you are acquiring it for in vitro or other controlled research work.

Who is allowed to order?

Purchasers must be 21 or older and are responsible for compliance with the law where they take delivery. We ship to research institutions, laboratories and qualified individual researchers in the United States only. We do not ship to jurisdictions where these compounds are restricted.

How do I read the certificate of analysis?

Check three things in order. First, the lot code on the certificate matches the lot listed on the product page and in your order. Second, where the report gives an HPLC purity, its chromatogram shows a single dominant peak at the stated figure; a blend's report shows a peak for each compound. Third, where the lab ran mass spectrometry, the measured mass matches the expected molecular weight of the compound. Anything that does not line up, send us the lot code.

How should it be stored?

Unopened vials keep at ambient temperature short term, as in transit; on arrival, refrigerate them at 2–8 °C, and keep them at −20 °C beyond three months. Reconstitute following your laboratory's own protocol; once in solution, refrigerate at 2–8 °C, protect from light and use within 30 days.

When does it ship and how?

Orders are normally prepared for shipment within 1–3 business days and ship to street addresses in the United States only — not to P.O. boxes or APO/FPO/DPO military addresses. Shipping is free on orders over $150 and a flat $14.95 below that.

What payment methods do you take?

We take credit and debit cards, paid securely at checkout. Bank transfers and purchase orders are not available at the moment.

What if a vial arrives damaged?

Keep the vial and all the packaging, photograph the damage and email support@pureforgelabs.com within 48 hours of delivery with your order number. Once the claim is verified, we replace the vial or refund what you paid for it. Please do not send anything back unless we ask you to — apart from damaged or incorrect items, all sales are final.

Do you handle bulk and wholesale orders?

Yes, by quote. The volume tiers on the product pages go up to five vials; for larger research quantities email support@pureforgelabs.com with the compounds and amounts, and we will quote per gram.

FOR RESEARCH USE ONLY. NOT FOR HUMAN OR VETERINARY CONSUMPTION. This product is intended solely for legitimate laboratory, analytical, and scientific research. It is not intended to diagnose, treat, cure, mitigate, or prevent any disease and is not intended for human or veterinary administration or consumption. All products are intended for research and identification purposes only. These products are not intended for human dosing, injection, or ingestion.

$59.99
Thymosin Alpha-1 · 10 mg · 1 vial

New compounds, restocks, lot releases.

One short email when something changes. No drip campaigns.